Fluoxetine brakes the menstrual cycle: Uncovering the unexpected effect
- PMID: 40376654
- PMCID: PMC12077640
- DOI: 10.4103/ipj.ipj_326_24
Fluoxetine brakes the menstrual cycle: Uncovering the unexpected effect
Abstract
Fluoxetine is one of the most commonly used antidepressants, classified under selective serotonin reuptake inhibitors (SSRIs). It is indicated for the treatment of depression, obsessive-compulsive disorder, anxiety, and eating disorders. The antidepressant effect of fluoxetine is achieved by inhibiting the reuptake of serotonin (5-HT) via the serotonin transporter (SERT) in neurons. Although fluoxetine is generally considered safe and well-tolerated by most patients, this case series describes instances where patients treated with fluoxetine subsequently developed menstrual irregularities. Upon discontinuation of fluoxetine, the menstrual cycles returned to normal. To the best of our knowledge, there is a lack of precise data associating fluoxetine with the onset of menstrual irregularities. This effect may be related to its central serotonergic action via 5-HT action modulates the prolactin, estradiol, and progesterone level. Therefore, physicians should be aware of the potential risk of fluoxetine-induced menstrual irregularities.
Keywords: Fluoxetine; SSRI; mensural irregularities.
Copyright: © 2025 Industrial Psychiatry Journal.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.Exp Brain Res. 2002 Mar;143(2):191-7. doi: 10.1007/s00221-001-0979-3. Epub 2002 Jan 24. Exp Brain Res. 2002. PMID: 11880895
-
Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.J Neurosci. 2023 Mar 29;43(13):2222-2241. doi: 10.1523/JNEUROSCI.1519-22.2022. Epub 2023 Mar 3. J Neurosci. 2023. PMID: 36868853 Free PMC article.
-
Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010. CNS Drugs. 1997. PMID: 23338224
-
[Fluoxetine: an update of its use in major depressive disorder in adults].Encephale. 2004 Jul-Aug;30(4):392-9. doi: 10.1016/s0013-7006(04)95453-x. Encephale. 2004. PMID: 15597466 Review. French.
-
Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2416-25. doi: 10.1098/rstb.2011.0361. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 22826342 Free PMC article. Review.
References
-
- Brambilla P, Cipriani A, Hotopf M, Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacopsychiatry. 2005;38:69–77. - PubMed
-
- Sohel AJ, Shutter MC, Patel P, Molla M. StatPearls [Internet] StatPearls Publishing; 2024. Fluoxetine. - PubMed
-
- Nicholas L, Dawkins K, Golden R. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am. 1998;21:341–58. - PubMed
-
- Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry. 1994;165:728–33. - PubMed
-
- Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, et al. A case with euprolactinemic galactorrhea induced by escitalopram. Int J Psychiatry Med. 2007;37:275–8. - PubMed
LinkOut - more resources
Full Text Sources